Comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement,...

por Scheper, Henk, de Boer, Mark G. J.
Publicado 2020

Rifampin for Staphylococcal Prosthetic Joint Infection: Do We Still Need a Randomized Controlled Trial?

por Scheper, Henk, De Boer, Mark G J
Publicado 2021

Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim–sulfamethoxazole: lessons from an observational cohort study

por Creemers-Schild, Dina, Kroon, Frank P., Kuijper, Ed. J., de Boer, Mark G. J.
Publicado 2015

Osteomyelitis caused by Streptococcus intermedius in immunocompetent adults — a case report and systematic literature review

por Brunink, Elyne M., Hoogervorst, Lotje A., Steentjes, Koen, Broekhuis, Demien, de Boer, Mark G. J.
Publicado 2023

Trends in antibiotic selection pressure generated in primary care and their association with sentinel antimicrobial resistance patterns in Europe

por Sijbom, Martijn, Büchner, Frederike L, Saadah, Nicholas H, Numans, Mattijs E, De Boer, Mark G J
Publicado 2023

Determinants of inappropriate antibiotic prescription in primary care in developed countries with general practitioners as gatekeepers: a systematic review and construction of a fr...

por Sijbom, Martijn, Büchner, Frederike L, Saadah, Nicholas H, Numans, Mattijs E, de Boer, Mark G J
Publicado 2023

Why crowding matters in the time of COVID-19 pandemic? - a lesson from the carnival effect on the 2017/2018 influenza epidemic in the Netherlands

por Chen, Qingui, Toorop, Myrthe M. A., de Boer, Mark G. J., Rosendaal, Frits R., Lijfering, Willem M.
Publicado 2020

Quality of Conduct and Reporting of Propensity Score Methods in Studies Investigating the Effectiveness of Antimicrobial Therapy

por Eikenboom, Anna M, Le Cessie, Saskia, Waernbaum, Ingeborg, Groenwold, Rolf H H, de Boer, Mark G J
Publicado 2022

Using local clinical and microbiological data to develop an institution specific carbapenem-sparing strategy in sepsis: a nested case-control study

por Lambregts, Merel M. C., Hendriks, Bart J. C., Visser, Leo G., Bernards, Sandra T., de Boer, Mark G. J.
Publicado 2019

Liver and kidney function in patients with Covid‐19 treated with remdesivir

por van Laar, Sylvia A., de Boer, Mark G. J., Gombert‐Handoko, Kim B., Guchelaar, Henk‐Jan, Zwaveling, Juliette
Publicado 2021

Mortality After Delay of Adequate Empiric Antimicrobial Treatment of Bloodstream Infection

por Lambregts, Merel M. C., Wijnakker, Roos, Bernards, Alexandra T., Visser, Leo G., le Cessie, Saskia, de Boer, Mark G. J.
Publicado 2020

Choice of therapeutic interventions and outcomes for the treatment of infections caused by multidrug-resistant gram-negative pathogens: a systematic review

por Nørgaard, Sarah Melissa, Jensen, Camilla Skaarup, Aalestrup, Josefine, Vandenbroucke-Grauls, Christina M. J. E., de Boer, Mark G. J., Pedersen, Alma Becic
Publicado 2019

Systematic screening for COVID‐19 associated invasive aspergillosis in ICU patients by culture and PCR on tracheal aspirate

por van Grootveld, Rebecca, van Paassen, Judith, de Boer, Mark G.J., Claas, Eric C.J., Kuijper, Ed J., van der Beek, Martha T.
Publicado 2021

Exploring the Barriers in the Uptake of the Dutch MRSA ‘Search and Destroy’ Policy Using the Cascade of Care Approach

por Westgeest, Annette C., Schippers, Emile F., Sijbom, Martijn, Visser, Leo G., de Boer, Mark G. J., Numans, Mattijs E., Lambregts, Merel M. C.
Publicado 2022

Influence of surface characteristics of implant materials on MRSA biofilm formation and effects of antimicrobial treatment

por van Dun, Sven C. J., Verheul, Mariëlle, Pijls, Bart G. C. W., van Prehn, Joffrey, Scheper, Henk, Galli, Federica, Nibbering, Peter H., de Boer, Mark G. J.
Publicado 2023

Cues to improve antibiotic-allergy registration: A mixed-method study

por Sijbom, Martijn, Braun, Karolina K., Büchner, Frederike L., van Bodegom-Vos, Leti, Hendriks, Bart J. C., de Boer, Mark G. J., Numans, Mattijs E., Lambregts, Merel M. C.
Publicado 2022

Effect of invasive aspergillosis on risk for different causes of death in older patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome

por van Grootveld, Rebecca, Masarotto, Valentina, von dem Borne, Peter A., Blijlevens, Nicole M. A., Chitu, Dana A., van der Beek, Martha T., Fiocco, Marta, de Boer, Mark G. J.
Publicado 2023

Influence of Polymorphisms in Innate Immunity Genes on Susceptibility to Invasive Aspergillosis after Stem Cell Transplantation

por de Boer, Mark G. J., Jolink, Hetty, Halkes, Constantijn J. M., van der Heiden, Pim L. J., Kremer, Dennis, Falkenburg, J. H. Frederik, van de Vosse, Esther, van Dissel, Jaap T.
Publicado 2011

SAAP-148 Eradicates MRSA Persisters Within Mature Biofilm Models Simulating Prosthetic Joint Infection

por Scheper, Henk, Wubbolts, Julia M., Verhagen, Joanne A. M., de Visser, Adriëtte W., van der Wal, Robert J. P., Visser, Leo G., de Boer, Mark G. J., Nibbering, Peter H.
Publicado 2021

Early differentiation between uncomplicated and complicated Staphylococcus aureus bacteraemia: Potential value and limitations of a clinical risk score

por Lambregts, Merel M. C., Molendijk, Eva B. D., Meziyerh, Soufian, Schippers, Emile F., Delfos, Nathalie M., Leendertse, Masja, Bernards, Alexandra T., Visser, Leo G., Dekkers, Olaf M., de Boer, Mark G. J.
Publicado 2020